Progress and challenges toward the development of vaccines against avian infectious bronchitis

Avian infectious bronchitis (IB) is a widely distributed poultry disease that has huge economic impact on poultry industry. The continuous emergence of new IBV genotypes and lack of cross protection among different IBV genotypes have been an important challenge. Although live attenuated IB vaccines...

Full description

Bibliographic Details
Main Authors: Bande, Faruku, Arshad, Siti Suri, Bejo, Mohd Hair, Moeini, Hassan, Omar, Abdul Rahman
Format: Article
Language:English
Published: Hindawi 2015
Online Access:http://psasir.upm.edu.my/id/eprint/46021/1/Progress%20and%20challenges%20toward%20the%20development%20of%20vaccines%20against%20avian%20infectious%20bronchitis.pdf
_version_ 1796974607763243008
author Bande, Faruku
Arshad, Siti Suri
Bejo, Mohd Hair
Moeini, Hassan
Omar, Abdul Rahman
author_facet Bande, Faruku
Arshad, Siti Suri
Bejo, Mohd Hair
Moeini, Hassan
Omar, Abdul Rahman
author_sort Bande, Faruku
collection UPM
description Avian infectious bronchitis (IB) is a widely distributed poultry disease that has huge economic impact on poultry industry. The continuous emergence of new IBV genotypes and lack of cross protection among different IBV genotypes have been an important challenge. Although live attenuated IB vaccines remarkably induce potent immune response, the potential risk of reversion to virulence, neutralization by the maternal antibodies, and recombination and mutation events are important concern on their usage. On the other hand, inactivated vaccines induce a weaker immune response and may require multiple dosing and/or the use of adjuvants that probably have potential safety risks and increased economic burdens. Consequently, alternative IB vaccines are widely sought. Recent advances in recombinant DNA technology have resulted in experimental IB vaccines that show promise in antibody and T-cells responses, comparable to live attenuated vaccines. Recombinant DNA vaccines have also been enhanced to target multiple serotypes and their efficacy has been improved using delivery vectors, nanoadjuvants, and in ovo vaccination approaches. Although most recombinant IB DNA vaccines are yet to be licensed, it is expected that these types of vaccines may hold sway as future vaccines for inducing a cross protection against multiple IBV serotypes.
first_indexed 2024-03-06T08:59:30Z
format Article
id upm.eprints-46021
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T08:59:30Z
publishDate 2015
publisher Hindawi
record_format dspace
spelling upm.eprints-460212022-05-31T20:47:59Z http://psasir.upm.edu.my/id/eprint/46021/ Progress and challenges toward the development of vaccines against avian infectious bronchitis Bande, Faruku Arshad, Siti Suri Bejo, Mohd Hair Moeini, Hassan Omar, Abdul Rahman Avian infectious bronchitis (IB) is a widely distributed poultry disease that has huge economic impact on poultry industry. The continuous emergence of new IBV genotypes and lack of cross protection among different IBV genotypes have been an important challenge. Although live attenuated IB vaccines remarkably induce potent immune response, the potential risk of reversion to virulence, neutralization by the maternal antibodies, and recombination and mutation events are important concern on their usage. On the other hand, inactivated vaccines induce a weaker immune response and may require multiple dosing and/or the use of adjuvants that probably have potential safety risks and increased economic burdens. Consequently, alternative IB vaccines are widely sought. Recent advances in recombinant DNA technology have resulted in experimental IB vaccines that show promise in antibody and T-cells responses, comparable to live attenuated vaccines. Recombinant DNA vaccines have also been enhanced to target multiple serotypes and their efficacy has been improved using delivery vectors, nanoadjuvants, and in ovo vaccination approaches. Although most recombinant IB DNA vaccines are yet to be licensed, it is expected that these types of vaccines may hold sway as future vaccines for inducing a cross protection against multiple IBV serotypes. Hindawi 2015 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/46021/1/Progress%20and%20challenges%20toward%20the%20development%20of%20vaccines%20against%20avian%20infectious%20bronchitis.pdf Bande, Faruku and Arshad, Siti Suri and Bejo, Mohd Hair and Moeini, Hassan and Omar, Abdul Rahman (2015) Progress and challenges toward the development of vaccines against avian infectious bronchitis. Journal of immunology Research, 2015. art. no. 424860. pp. 1-12. ISSN 2314-8861; ESSN: 2314-7156 https://www.hindawi.com/journals/jir/2015/424860/ 10.1155/2015/424860
spellingShingle Bande, Faruku
Arshad, Siti Suri
Bejo, Mohd Hair
Moeini, Hassan
Omar, Abdul Rahman
Progress and challenges toward the development of vaccines against avian infectious bronchitis
title Progress and challenges toward the development of vaccines against avian infectious bronchitis
title_full Progress and challenges toward the development of vaccines against avian infectious bronchitis
title_fullStr Progress and challenges toward the development of vaccines against avian infectious bronchitis
title_full_unstemmed Progress and challenges toward the development of vaccines against avian infectious bronchitis
title_short Progress and challenges toward the development of vaccines against avian infectious bronchitis
title_sort progress and challenges toward the development of vaccines against avian infectious bronchitis
url http://psasir.upm.edu.my/id/eprint/46021/1/Progress%20and%20challenges%20toward%20the%20development%20of%20vaccines%20against%20avian%20infectious%20bronchitis.pdf
work_keys_str_mv AT bandefaruku progressandchallengestowardthedevelopmentofvaccinesagainstavianinfectiousbronchitis
AT arshadsitisuri progressandchallengestowardthedevelopmentofvaccinesagainstavianinfectiousbronchitis
AT bejomohdhair progressandchallengestowardthedevelopmentofvaccinesagainstavianinfectiousbronchitis
AT moeinihassan progressandchallengestowardthedevelopmentofvaccinesagainstavianinfectiousbronchitis
AT omarabdulrahman progressandchallengestowardthedevelopmentofvaccinesagainstavianinfectiousbronchitis